SCHEMBL23647741

SCHEMBL23647741

Cc1cc(-c2cc(F)cc3c(I)c[nH]c23)c(C(F)(F)F)c2c1NC(C)(C)c1nnc(C)n1-2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30005987 1.00 — —
SCHEMBL30005645 0.89 — —
SCHEMBL23648088 0.89 — —
SCHEMBL24767040 0.86 — —
SCHEMBL23647842 0.85 NR3C1 (0.44) —
SCHEMBL30006237 0.85 NR3C1 (0.44) —
SCHEMBL30006121 0.81 REN (0.36) —
SCHEMBL23658431 0.81 REN (0.36) —
SCHEMBL23647964 0.79 REN (0.31) —
SCHEMBL30006347 0.79 REN (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4090660-B1 QUINOXALINE DERIVATIVES GRUENENTHAL GMBH (DE) 2024-01-31 — — EP disclosed
US-20220396578-A1 QUINOXALINE DERIVATIVES GRUENENTHAL GMBH (DE) 2022-12-15 — — US disclosed
WO-2021144439-A1 QUINOXALINE DERIVATIVES Grünenthal GmbH (DE) 2021-07-22 — — WO disclosed
Send feedback